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INTRODUCTION
Administration of the immunosuppressive drug cyclo-
sporine (CsA) after syngeneic or autologous bone marro w
transplantation (BMT) elicits a T- l y m p h o c y t e – d e p e n d e n t
autoimmune syndrome with pathology similar to that of
graft-versus-host disease (GVHD), which occurs after allo-
geneic BMT [1,2]. The onset of this autoaggression syn-
d rome, syngeneic GVHD, resembles acute GVHD with
e p i d e rmal lymphocyte infiltration and epithelial cell
d e s t ruction [3]. After onset of the acute phase, the disease
rapidly progresses to a more chronic type, with development
of complete alopecia and scleroderma with its relevant his-
tologic features (ie, fibrosis) [4,5]. The induction of this
autoaggression syndrome is, in large part, due to the ability
of CsA to inhibit the thymic-dependent clonal deletion of
autoreactive T cells [6,7]. In addition, the preparative regi-
men used for BMT eliminates a peripheral regulatory com-
ponent, thus providing a permissive environment for the
autoreactive T cells to manifest autoaggression [8,9].
The onset of CsA-induced syngeneic GVHD is associ-
ated with the development of a highly restricted re p e rt o i re of
C D 8+ a u t o reactive T cells, which promiscuously re c o g n i z e
major histocompatibility complex (MHC) class II molecules
[10,11]. MHC class II recognition occurs even in the absence
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ABSTRACT
Administration of the immunosuppressive drug cyclosporine after syngeneic or autologous bone marrow transplanta-
tion elicits a T-lymphocyte–dependent autoimmune syndrome similar to graft-versus-host disease (GVHD). The
onset of this autoaggression syndrome, termed syngeneic GVHD, is associated with the development of a highly
restricted re p e rt o i re of CD8+ a u t o reactive T cells that recognize a peptide from the invariant chain, termed CLIP,
p resented by major histocompatibility complex (MHC) class II molecules. Clonal analysis reveals 2 distinct subsets of
a u t o reactive T cells defined by their activation re q u i rement for either the N-terminal or the C-terminal fla n k i n g
regions of CLIP and by their cytokine pro file. The studies here reveal that the autoreactive T-cell clones re q u i r i n g
the N-terminal flanking region of CLIP produce type 1 cytokines (interf e ron [IFN]-γ , interleukin [IL]-2, and tumor
n e c rosis factor-α). In contrast, the autoreactive T-cell clones that re q u i re the C-terminal flanking region of CLIP
p roduce type 2 cytokines (IL-4, IL-10, transforming growth factor-β). As assessed in a local graft-versus-host re a c-
tion assay, the N-terminal fla n k i n g - restricted clones mediate changes consistent with acute GVHD, whereas the
clones responsive to the C-terminal flanking region do not. More o v e r, the autoreactive T-cell clones restricted by the
C - t e rminal flanking region of CLIP ameliorate the pathogenic potential of the cells responsive to the N-term i n a l
flanking region of CLIP. The mechanism accounting for this re g u l a t o ry affect appears to be the downregulation of
mRNA message for type 1 cytokines (IFN-γ and IL-2). The C-term i n a l – restricted autoreactive T-cell clones, how-
e v e r, could manifest disease with dermal changes similar to those seen in chronic syngeneic GVHD, provided that
I F N -γ was present. Consistent with these observations was the demonstration that type 1 cytokines are pre f e re n t i a l l y
detected during the acute phase of syngeneic GVHD, whereas type 2 cytokines dominate during the chronic phase.
The results suggest that acute and chronic syngeneic GVHD is mediated by distinct autoreactive T cells, which are
separated by their fine specificity for the CLIP-MHC class II complex and by their cytokine pro fil e s .
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of the classic cell surface restriction element (CD4). In the
Lewis rat model of syngeneic GVHD, the pre d o m i n a n t
a u t o reactive population expresses the Vβ 8.3/8.5 T- c e l l
receptor V- region gene segment [11]. Adoptive transfer stud-
ies have confirmed that the CD8+ Vβ 8 . 5+ T cells that develop
during CsA treatment are responsible for initiation of this
a u t o a g g ression syndrome and for the acute phase of syn-
geneic GVHD.
Recent studies characterizing the fine specificity of the
e ffector mechanisms in syngeneic GVHD reveal that the
pathogenic T lymphocytes recognize a peptide from the
MHC class II invariant chain (CLIP) presented in the con-
text of MHC class II [12-14]. Furthermore, there appears to
be a functional interaction between the T-cell receptor and
the flanking regions of CLIP (peptide sequences that extend
beyond the binding domain of the MHC class II molecule),
which may partially explain the promiscuous specificity of
the autoreactive T cells [12]. At the clonal level, there
appear to be 2 functionally discrete subsets of autore a c t i v e
T cells defined by their activation requirement for either the
N-terminal or the C-terminal flanking regions of CLIP and
by their cytokine profile [12,14]. The autoreactive T- c e l l
clones requiring the N-terminal flanking region of CLIP
p roduce type I (interf e ron [IFN]-γ , interleukin [IL]-2)
cytokines. In contrast, the autoreactive T-cell clones
that re q u i re the C-terminal flanking region of CLIP
p roduce type 2 cytokines (IL-4, IL-10). Most impor-
tant, the N-terminal flanking region restricted clones,
when assessed in an in vivo local graft-versus-host reaction
(GVHR) assay, induce histologic changes consistent with
acute GVHD, whereas the clones responsive to CLIP with
the C-terminal flanking region did not.
The studies presented here further characterize the
pathogenic potential of the N-terminal and C-term i n a l
C L I P - a u t o reactive T-cell clones and their potential re l a-
tionship to the acute and chronic phases of syngeneic
GVHD. The results using a local GVHR assay reveal that
only the autoreactive T-cell clones restricted by the
N -t e rminal region of CLIP mediate epidermal damage
consistent with acute GVHD. It is interesting that mixing
experiments demonstrate that the autoreactive T- c e l l
clones producing type 2 cytokines and restricted by the
C - t e rminal flanking region of CLIP ameliorated the
p a th o gen i c  p ot e n t i a l  o f  th e  cel l s  r esp o ns iv e  t o
t he  N-t e rminal flanking region of CLIP. Although
the C- t e rm i n a l – restricted autoreactive T-cell clones had
the re g u l a t o ry potential to suppress the damage occurr i n g
during the acute phase of syngeneic GVHD, this is not
without pathologic consequence.
The C term i n a l – restricted autoreactive T-cell clones
induce deep dermal changes consistent with the chro n i c
phase of syngeneic GVHD. Consistent with these results are
the findings evaluating cytokine pro files observed in tissues
taken from animals in either the acute or the chronic phase of
syngeneic GVHD. Type 1 cytokines were pre f e re n t i a l l y
detected during the acute phase of this autoaggression syn-
d rome, whereas type 2 cytokines dominated during the
c h ronic phase. Taken together, the results suggest that
c h ronic syngeneic GVHD may be a compensatory mecha-
nism in response to the acute phase of this autoaggre s s i o n
s y n d ro m e .
MATERIALS AND METHODS
Induction of Syngeneic GVHD
C o ro n a v i ru s - f ree, female Lewis rats 4 to 6 weeks of age
(Charles River Breeding Laboratories, Wilmington, MA)
received syngeneic BMT after total-body irr a d i a t i o n
(10.5 Gy) as previously described [10]. Recipient animals
w e re treated daily with 10 mg/kg CsA (dissolved in 0.02%
ethanol and 5% Emulphor in H2O) for 30 days. Syngeneic
GVHD developed within 2 weeks after the untapered with-
drawal of CsA and was confirmed by histologic examination
of ear and skin biopsies as described pre v i o u s l y. Eff e c t o r
spleen cells were adoptively transferred into secondary
thymectomized Lewis rats reconstituted with T-c e l l – d e p l e t e d
bone marrow to allow for selective clonal expansion and yielded
a highly enriched population of autoreactive T cells [11].
Isolation of Autor e a c t i v e T-Cell Clones
The isolation and initial characterization of CD8+ (con-
firmed flow cytometrically) autoreactive T-cell clones from
Lewis rats with syngeneic GVHD are described in detail
elsewhere [12,14]. Briefly, lymphocytes from spleens, lymph
nodes, and peripheral blood from secondary recipients with
biopsy-confirmed syngeneic GVHD were cultured at limit-
ing dilution using irradiated (30 Gy) syngeneic spleen cells
as antigen-presenting cells in complete tissue culture
medium containing IL-2 (10 U/mL). The clones were
expanded by restimulation (every 7-10 days) with irradiated
syngeneic spleen cells (2 × 1 04 cells per macrotiter well).
The in vitro specificity of the effector T cells was defin e d
using a 3H thymidine-based assay (JAM) test to measure
their ability to kill peptide-loaded target cells.
Cell-Mediated L y m p h o l ysis Assay
Killing activity was assessed using a 3H thymidine-based
assay (JAM) test, as described by Matzinger [15], which
m e a s u res DNA fragmentation and cell death. The targ e t
cells (phytohemagglutinin blast cells; 5-10 3 1 06) were
pulsed with 2.5 µCi/mL 3H thymidine for 18 hours and
washed 3 times before assay. Graded numbers (1 3 1 04 t o
1 3 1 05) of the effector T-cell clones and the target cells
(5 3 103) co-incubated for 4 hours before harvest. Variabil-
ity between replicate cultures averaged less than 5%.
CLIP P e p t i d e s
Rat CLIP (amino acids 82-103; PKSAKPVSPMRMAT-
PLLMRPLS) and the truncated variants (amino acids
9 0-104 and 86-100, containing MHC class II binding
domain with either the N-terminal or C-terminal fla n k i n g
region) were chemically synthesized and purified by high-
pressure liquid chromatography by Quality Controlled Bio-
chemicals (Hopkinton, MA) [12,14,16]. The peptides
(>92% purity) were diluted to 10 µmol/L in RPMI 1640
before loading MHC class II–positive lymphoblasts as previ-
ously described [12,14]. Previous dose-response studies
revealed that maximal enhancement of killing was achieved
by pretreating the target cells with 1 µmol/L peptide.
RNA Pr e p a r a t i o n
RNA was extracted and purified with Trizol reagent (Life
Technologies, Gaithersburg, MD), according to the pro t o c o l
p rovided by the manufacturer [14]. In brief, the cloned T c e l l s
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w e re harvested and washed twice in phosphate-buff e re d
saline. Cell lysate was pre p a red from 5 × 1 04 cells in 500 µL
Trizol reagent with adequate mixing. After adding 100 µL
c h l o ro f o rm, the solution was well mixed and centrifuged. The
s u p e rnatant was collected and extracted once with chlorof o rm .
RNA was precipitated with 2-propanol and rinsed with
70% ethanol. Purified RNA was dissolved in 20 µL diethyl
p y ro c a r b o n a t e – t reated distilled water.
R eve r s e - T ranscription P o l ymerase Chain Reaction
cDNA was pre p a red with Ready-To-Go re v e r s e - t r a n-
scription (RT) kit (Pharmacia Biotech, Piscataway, NJ)
according to the protocol provided by the manufacturer. RT
reaction was perf o rmed in a total volume of 33 µL and
primed with random hexamer. For each sample, 2 RT reac-
tions were conducted, the cDNA products were pooled, and
2 µL of cDNA were used for polymerase chain re a c t i o n
(PCR). Oligonucleotide primers used PCR for analysis of
cytokines were previously reported [14]. For cytokine analy-
sis of the T-cell clones, actin was also amplified as a semi-
quantitative indicator of cDNA used in each reaction. For
quantitative PCR of target tissue, control templates were
constructed as follows and are listed in Table 1 [17].
For the IL-2 control template, a 255-base pair (bp) frag-
ment was inserted at the C1a restriction site yielding a larg e r
(605-bp) product compared with the normal or unmodifie d
350-bp product. A similar strategy was used for the IFN-γ
c o n t rol template inserting a 157-bp fragment at the Av aI I I
restriction site with a 385-bp product compared with a 228-
bp product for the unmodified product. Control templates
for IL-4 and IL-10 used an excision strategy. For the IL-4
c o n t rol template, a 110-bp fragment was excised between
2 Tth111 II restriction sites yielding a smaller product (202
bp) compared with the unmodified primer product (313 bp).
For IL-10, a 240-bp fragment between the D R dI and P s tI
restriction sites was excised. The control template pro d u c t
(106 bp) was smaller than the unmodified product (346 bp).
The PCR was conducted in a total volume of 25 µL con-
taining 20 mmol/L Tris-HCl (pH 8.4), 50 mmol/L KC1,
1.5 mmol/L MgCl2, 200 µmol/L deoxynucleotides (dNTP),
100 nmol/L each of the primers, and 5 U Ta q DNA poly-
merase (Life Technologies). The thermal cycler (Perkin-
E l m e r, Branchburg, NJ) was programmed as 95°C 3 1
minute, 60°C 3 1 minute, 72°C 3 1 minute, 30 cycles. The
PCR products were extracted with chloro f o rm, and elec-
t ro p h o resis was perf o rmed on a 1.5% agarose gel. Gels were
stained with ethidium bromide to visualize the bands. For
quantitative PCR, the gels were scanned densitometrically,
and the ratio between the signals for the control template
and the unmodified product (sample) were compare d .
Local Graft-versus-Host Reaction Assay
A local GVHR (footpad) assay was used to evaluate the
pathogenic potential of the autoreactive T-cell clones as
p reviously described [12,18]. Briefly, the diff e rent clones
(5 3 1 04 cells) were injected singly or in combination (in a
volume of 50 µL) into individual footpads of Lewis rats.
N o rmal spleen cells were used as controls and showed no
demonstrable histopathology [12]. Before injection, the
animals received total-body irradiation (5 Gy) to eliminate
potential peripheral re g u l a t o ry mechanisms [8,9]. After 48
or 96 hours, the animals were killed and the tissues
e x a mined histological ly  for lymphocyte infiltrat ion
into the e p id e rmis and for epithelial cell destru c t i o n
( a p o p t o s i s /dyskeratosis). In addition, rat recombinant IFN-
γ (100 U, Gibro BRL, Grand Island, NY) was coadminis-
t e red with the clones of effector T cells. Tissue samples
w e re coded and read in a double-blinded fashion. Histo-
logic damage (acute-type GVHD) was quantified accord-
ing to the scale, described in Results, ranking the number
of apoptotic/dyskeratotic cells associated with infiltrating
lymphocytes into the epidermis per high-power field eval-
uating 20 high-power fields on 3 serial sections. The tis-
sues were also examined for histopathology in the derm i s
and deep derm i s .
RESULTS
P revious studies found that 2 functionally distinct subsets
of CD8+ a u t o reactive T cells can be isolated from limiting
dilution cultures of lymphocytes from animals with syngeneic
Table 1. Oligonucleotide Primers Used for Competitive Polymerase Chain
Reaction*
Cytokine Sequence 
IL-2
Sense GCG CAC CCA CTT CAA GCC CT
Antisense CCA CCA CAG TTG CTG GCT CA
1FN- γ
Sense GCC ATC AGC AAC AAC ATA AGT
Antisense CAG AAT CAG CAC CGA CTC CTT
IL-4
Sense CGT CAC TGA CTG TAG AGA GC
Antisense ACC GAG AAC CCC AGA CTT GT
IL-10
Sense TGC CTT CAG TCA AGT GAA GAC T
Antisense AAA CTC ATT CAT GGC CTT GTA
*IFN indicates interferon; IL, interleukin.
Table 2. MHC Class II-CLIP-Reactive T-Cell Clones*†
N-Terminal CLIP-Restricted C-Terminal CLIP-Restricted
TcR restriction Vβ 8.5/V α 11(n = 20); V β 8.5/V α 10 (n = 2) V β (multiple)/V α 10 (n = 10)
Cytokine production IL-2; IFN- γ (type 1) IL-4; IL-10 (type 2)
*IFN indicates interferon; IL, interleukin; MHC, major histocompatibility complex; TcR, T-cell receptor.
†Clones were established from Lewis rats with early-onset syngeneic graft-versus-host-disease, and restriction was determined by in vitro killing assays.
TcR Vα/ Vβ restriction and cytokine production were assessed by reverse transcription polymerase chain reaction [12,14].
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GVHD, as summarized in Table 2 [12,14]. The dominant
a u t o reactive T-cell subset in animals during the early onset of
syngeneic GVHD re q u i res the N-terminal flanking region of
CLIP for in vitro activity. A second subset of autoreactive T
cells can be isolated, one which responds only to variants of
CLIP containing the C-terminal flanking region. Figure 1
p rovides a typical lytic pro file for re p resentative N-term i n a l –
and C-term i n a l – restricted T-cell clones. The N-term i n a l
restricted clone pre f e rentially kills target cells loaded with
either parent CLIP or the truncated variant of CLIP contain-
ing the N-terminal flanking region. In the absence of this
flanking region, minimal killing was observed and re fle c t e d
weak specificity for the MHC class II binding domain of
CLIP [12,14]. A re c i p rocal pattern was observed for the clone
dependent on the C-terminal flanking region of CLIP. These
2 functionally distinct subsets of clones could also be sepa-
rated on the basis of their T-cell receptor re p e rt o i re (Table 2).
The clones that re q u i red the N-terminal flanking region of
CLIP were largely restricted to cells expressing the Vβ 8 . 5
and Vα 11 T-cell receptor gene elements. A few clones with
this specificity express Vβ 8.5 and Vα 10. In contrast, the
a u t o reactive T cells by CLIP variants having the C-term i n a l
flanking region were restricted to Vα 10 T-cell receptor gene
utilization. An array of Vβ gene elements, however, was
detected in this subset of autoreactive T cells [14].
These 2 distinct subsets of autoreactive T cells were
polarized with respect to their cytokine mRNA pro files as
detected by RT-PCR. As shown in Figure 2 for 2 re p re s e n t a-
tive clones, mRNA for type 1 cytokines (IL-2, IFN-γ, tumor
n e c rosis factor [TNF]-α) was detected in the clone re s t r i c t e d
by the N-terminal flanking region of CLIP, whereas mRNA
for type 2 cytokines (IL-4, IL-10, transforming growth fac-
tor [TGF]-β) was pre f e rentially expressed in the clone
restricted by the C-terminal flanking region of CLIP. The
cytokine pro file, specific i t y, and T-cell receptor re s t r i c t i o n
w e re consistent for 20 N-term i n a l – restricted and 10 C-term i n a l–
restricted autoreactive T-cell clones.
P revious studies evaluating a limited number of autore-
active T-cell clones revealed that the autoreactive T- c e l l
clones that re q u i red the N-terminal flanking region of CLIP
for in vitro activity were pathogenic in vivo as assessed in a
local GVHR assay. These clones mediated histologic
changes consistent with acute GVHD, marginating thro u g h
F i g u r e 1. Representative lytic profiles for N-terminal and C-terminal CLIP-major histocompatibility complex class II autoreactive T-cell clones. The cloned
T cells were assessed for their ability to kill target cells loaded with truncated variants of CLIP. Effector to target ratio was 10:1. The data are expressed as percent
specific killing.
F i g u r e 2. Cytokine analysis of representative N-terminal and C-terminal
CLIP-major histocompatibility complex class II autoreactive T-cell clones.
Clones were analyzed for type 1 (IL-2, IFN-γ, IFN-α ) and type 2 (IL-4,
I L -10, transforming growth factor [TGF]-β ) mRNA by reverse transcrip-
tion-polymerase chain reaction. Actin was also amplified in each reaction to
serve as a control semiquantitative indicator for cDNA. MW Stds indicates
molecular weight standards.
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the epiderm a l - d e rmal junction, and were associated with
significant epithelial damage (apoptosis/dyskeratosis). The
a u t o reactive T-cell clones that re q u i red the C-term i n a l
flanking region of CLIP did not induce significant epithelial
damage in this assay. Because of the cytokine polarization
between the 2 subsets, the C-term i n a l – restricted clones were
evaluated for re g u l a t o ry potential in the local GVHR assay.
A u t o reactive T-cell clones requiring the N-terminal or
C -t e rminal fragment of CLIP for in vitro activity (including
the clones shown in Figures 1 and 2 and activity assessed in
F i g u re 3A, B, C) were injected singly or in combination into
footpads of syngeneic Lewis rats. After 48 hours, the animals
w e re killed and the tissues examined histologically for evi-
dence of a GVHR.
As shown in Figure 3A, D, and G, the 3 autore a c t i v e
T-cell clones that re q u i re the N-terminal flanking region of
CLIP mediate significant epithelial damage within the epi-
d e rmis. There was an intense infiltrate of lymphocytes into
the epidermis with substantial epithelial cell destru c t i o n
(apoptosis/dyskeratosis). No significant changes were
o b s e rved in the dermis. In contrast, minimal epidermal dam-
age occurred when the autoreactive T-cell clones re s t r i c t e d
by the C-terminal fragment of CLIP were injected into the
footpad. Here, the autoreactive T-cell clones were sparsely
distributed in the dermis and deep dermis (Figure 3B, E, and
H). Of interest, however, are the results when mixtures of
the clones were injected into the footpad. As shown in Fig-
u re 3C, F, and I, a marked diminution of epithelial cell
d a mage was seen with, at most, only a sparse infiltrate of
lymphocytes into the epidermis. Almost identical re s u l t s
w e re observed with 7 randomly selected N-terminal and
C -t e rminal restricted clones with a >85% reduction of
epithelial cell destruction (as judged by a decrease in the
number of apoptotic/dyskeratotic cells/high-power fie l d ) .
The autoreactive T-cell clones that re q u i re the C-term i n a l
fragment of CLIP for in vitro activity clearly have the ability
to ameliorate the pathogenic potential of the N-term i n a l
CLIP autoreactive T-cell subset. Initial studies exploring the
Figure 3. Pathogenicity and regulatory effects of N-terminal and C-terminal CLIP-major histocompatibility complex (MHC) class II autoreactive T-cell clones.
Three randomly selected sets of N-terminal and C-terminal CLIP-MHC class II autoreactive T-cell clones (5 × 104 in 50 µL tissue culture medium) were injected
singly (N-terminal; A, D, G; C-terminal: B, E, H) or in combination (C, F, I) into footpads of irradiated (5 Gy) Lewis rats. After 48 hours, the rats were killed
and the tissues examined histologically (hematoxylin-eosin, original magnification ×100). Note the dense infiltrate of lymphocytes at the epidermal-dermal junction
(A, D, G, arrows).
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underlying mechanism for this re g u l a t o ry effect measure d
the ability of the C-terminal–restricted clones to recognize
and kill the N-terminal CLIP-restricted subset. The re s u l t s
f rom these experiments were negative and found no signifi-
cant killing (data not shown). Additional studies assessed
whether the C-terminally CLIP-reactive T-cell subset
induced a downregulation of cytokine mRNA message in
the pathogenic T-cell clones. The N-t e rm i n a l – re s t r i c t e d
and C-t e rm i n a l – restricted CLIP autoreactive T-cell sub-
sets were incubated separately or together for 3 h o u r s .
After incubation, the cells were harvested and analyzed by
RT-PCR for type 1 cytokines.
As shown in Figure 4, significant levels of mRNA mes-
sage for IL-2 present in the N-term i n a l – restricted clones
were markedly diminished in the mixed cultures. Similarly,
mRNA message for IFN-γ was also markedly downre g u-
lated in 3 of 4 mixed cultures (Figure 5). In contrast,
assessment of message for type 2 cytokines produced by
the C-t e rm i n a l – restricted clones revealed no significant
changes in expression in the mixed cultures (data not
shown). Although the autoreactive T-cell clones that require
the C-terminal flanking region of CLIP were able to effec-
tively kill target cells loaded with peptides in vitro, these
autoreactive T-cell clones were not pathogenic when tested
in the 48-hour local GVHR assay. This length of time may
have been too short to detect the pathogenic potential of
this autoreactive T-cell subset. On the other hand, the tar-
get antigen may not have been sufficiently expressed.
Subsequent studies evaluated whether this subset of
a u t o reactive T-cell clones could manifest autoaggre s s i o n
when the incubation time was increased (96 hours) with or
without the coadministration of IFN-γ. Several autore a c-
F i g u r e 5. Reverse transcription-polymerase chain reaction (RT-PCR) analysis for IFN-γ mRNA in co-cultured clones. Four sets of N-terminal (N) and
C - t e rminal (C) CLIP-major histocompatibility complex class II autoreactive T-cell clones (5 × 104) were cultured singly or in combination (N + C) for 3 hours fol-
lowed by RT-PCR analysis for IFN-γ mRNA. Actin cDNA was included in each reaction as a control. MW Stds indicates molecular weight standards.
F i g u r e 4. Reverse transcription-polymerase chain reaction ( RT-PCR) analysis for IL-2 mRNA in co-cultured clones. Three sets of N-terminal (N) and
C - t e rminal (C) CLIP-major histocompatibility complex class II autoreactive T cell clones (5 3 104) were cultured singly or in combination (N + C) for 3 hours.
After incubation, the cells were analyzed for IL-2 mRNA by reverse transcription-polymerase chain reaction. Actin cDNA was included as a semiquantitave con-
trol in each reaction. MW Stds indicates molecular weight standards. 
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tive T-cell clones that re q u i re the C-terminal flanking
region of CLIP and were confirmed to secrete type 2
cytokines were injected into footpads of syngeneic Lewis
rats, either alone or mixed with 100 U of rat IFN-γ b e f o re
injection. After 96 hours, the rats were killed and the tis-
sues examined h i s t o l o g i c a l l y. As shown in Figure 6A, the
a u t o reactive T-cell clone that re q u i res the C-term i n a l
flanking region of CLIP were located primarily in the der-
mis and deep dermis. There was, however, little histologic
damage compared with control tissues (Figure 6C, D). In
contrast, remarkable histologic damage occurred when the
a u t o reactive T-cell clones were injected with IFN-γ ( F i g-
u re 6B). Dense infiltrates of the autoreactive T cells in the
d e rmis and deep dermis were observed with marked
d e s t ruction of the dermis and remarkable swelling. The
d e rmal destruction was often associated with fibrin deposi-
tion (Figure 7A) and lymphocyte infiltration into the mus-
cular layer (Figure 7C). Most of the histologic damage was
confined to the dermis and deep dermis. There was also
focal damage with apoptotic/dyskeratotic cells at the epi-
d e rm a l / d e rmal junction (Figure 7E). Interstitial inflamma-
tion (and early fibrosis?) often compacted the eccrine
glands (Figure 7G).
C o m p a r a t i v e l y, little histopathology was observed after
96 hours when the clones were injected in the absence of
I F N -γ ( F i g u re 7B, D, F, H). Of 10 C-term i n a l – re s t r i c t e d
clones tested, IFN-γ always potentiated their ability to
manifest autoaggression. It is interesting that coinjection
of N-terminal– and C-term i n a l – restricted clones re v e a l e d
little dermal pathologic findings even when analyzed after
96 hours (data not presented). The failure to detect signifi-
cant pathology was most likely due to the downre g u l a t i o n
of IFN-γ p roduction (Figure 5).
The studies just described demonstrate that the
a u t o reactive T-cell clones that re q u i re the N-term i n a l
flanking region of CLIP primarily mediate epidermal dam-
age. On the other hand, the autoreactive T-cell clones that
re q u i re the C-terminal flanking region of CLIP mediate
tissue damage primarily within the dermis and deep derm i s
but only when IFN-γ was present. The tissue distribution
of histologic damage (epiderm i s / d e rmis) is consistent with
the damage observed during acute and chronic GVHD.
The next series of studies evaluated the cytokine pro-
file of tissue infiltrating lymphocytes during the acute and
c h ronic phases of syngeneic GVHD. Ta rget tissue (tongue)
was harvested during the acute phase or the chronic phase
of syngeneic GVHD and evaluated for type 1 and type 2
cytokines by quantitative PCR. As shown in Figure 8, mes-
sage for type 1 cytokines (IL-2, IFN-γ) was detected pri-
marily during the acute phase of syngeneic GVHD. Mes-
sage for type 2 cytokines could not be detected in the
t a rget tissues from animals with acute syngeneic GVHD.
In contrast, during the chronic phase of syngeneic GVHD,
mRNA for type 2 cytokines (IL-4, IL-10) was principally
detected. Little, if any, message for type 1 cytokines could
be detected. Of interest is the failure to detect any message
for either type 1 or type 2 cytokines in an animal that
resolved the acute phase of syngeneic GVHD but failed to
p ro g ress to the chronic phase of syngeneic GVHD. A simi-
lar pattern emerged when the tissues were analyzed for
F i g u r e 6. The pathogenic potential of C-terminal CLIP-major histocompatibility complex (MHC) class II autoreactive T cells is augmented by IFN-γ. A
C - t e rminal CLIP-MHC class II autoreactive T-cell clone (5 × 104) was injected with (B) or without (A) 100 U IFN-γ into footpads of irradiated (5 Gy) Lewis
rats. After 96 hours, the animals were killed and the tissues examined histologically. Note the intense lymphocyte infiltrate and swelling in the dermis when the
clone T cells were injected with IFN-γ (B; arrows). The control samples with (D) or without (C) IFN-γ showed no significant damage mediated by normal T lym-
phocytes (hematoxylin-eosin, original magnification ×64).
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mRNA message for TNF-α and TGF-β ( F i g u re 9). As
assessed by RT-PCR, message for TNF-α was detected
principally during the acute phase of syngeneic GVHD,
w h e reas message for TGF-β was predominant during the
c h ronic phase. Animals followed up sequentially by evalu-
ating skin biopsies revealed a similar shift in type 1 and
type 2 cytokine profiles as the disease pro g ressed from the
acute to the chronic phase.
DISCUSSION
P revious studies in our laboratory revealed that syn-
geneic GVHD is mediated by a highly conserved repertoire
of CD8+ Vβ 8 . 5+ T cells that promiscuously re c o g n i z e
MHC class II determinants [10,11]. Recognition of MHC
class II molecules by the autoreactive T cells is facilitated by
the presentation and recognition of a peptide from the
invariant chain, CLIP [12-14]. Essential for the pro m i s c u-
Figure 7. Representative dermal pathology mediated by C-terminal CLIP-major histocompatibility complex (MHC) class II autoreactive T-cell clones. Four differ-
ent C terminal CLIP-MHC class II autoreactive T-cell clones were injected with (A, C, E, G) or without (B, D, F, H) 100 U of interferon-γ into footpads of irradi-
ated (5 Gy) Lewis rats. After 96 hours, the rats were killed and the tissues examined histologically for differential pathology within the dermis. Examination of the
tissues revealed dermal destruction, swelling, fibrin deposition (A), lymphocytic infiltration into the muscles (C), epidermal-dermal infiltration with epithelial cell
destruction (E) and interstitial inflammation with compaction of the eccrine glands (G) (hematoxylin-eosin, original magnification 31 0 0 ) .
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ous recognition of MHC class II is the interaction between
the flanking regions of CLIP that extend beyond the MHC
class II binding groove and the T-cell receptor [12]. At the
clonal level, however, 2 functionally discrete subsets of
T cells can be isolated, which require either the N-terminal
or the C-terminal flanking region of CLIP. More o v e r, the
2 subsets of autoreactive clones can be separated by their
cytokine pro file and also by their ability to mediate histo-
logic damage in a local GVHR assay. The autoreactive T-cell
clones recognizing the MHC class II-CLIP complex and
dependent on the N-terminal flanking region of CLIP pro-
duce type 1 cytokines and mediate histologic changes con-
sistent with an acute GVHR (with marked epithelial cell
d e s t ruction and dyskeratosis). In contrast, autore a c t i v e
clones requiring the C-terminal flanking region of CLIP
p roduce type 2 cytokines and do not induce epithelial cell
destruction when assessed in the local GVHR assay.
The results from the present studies confirm and extend
these initial findings. The N-term i n a l – restricted CLIP-
a u t o reactive T-cell clones consistently induce changes
resembling an acute GVHR with remarkable infiltration
into the epidermis associated with significant epithelial cell
d e s t ruction (apoptosis/dyskeratosis). Analysis of cytokines
confirm that these autoreactive T-cell clones produce IL-2
and IFN-γ. In addition, the current studies reveal that the
N - t e rminal– restricted autoreactive T cells also pro d u c e
TNF-α. The production of type 1 cytokines may underlie,
in part, the pathogenicity of the N-term i n a l – re s t r i c t e d
clones. Release of IFN-γ in the target tissue leads to the
u p regulation of the MHC class II complex [18]. In fact,
recent studies indicate that the MHC class II-CLIP antigen
complex is upregulated in the target tissue by IFN-γ during
active syngeneic GVHD [14]. In addition, the production of
T N F -α could trigger the intracellular biochemical cascade
leading to apoptosis of the epithelial cells [19].
Although the autoreactive T-cell clones that re c o g n i z e
the MHC class II-CLIP complex and are dependent on the
C - t e rminal flanking region can functionally recognize targ e t
cells in vitro, these cells could not induce histologic changes
consistent with an acute GVHR when assessed in vivo.
Cytokine analysis reveals that this subset secretes type 2
cytokines (IL-2, IL-10) as well as TGF-β, as documented in
the present studies. It is surprising that this subset of autore-
active T-cell clones appears to have immunore g u l a t o ry
potential. The C-term i n a l – restricted CLIP-autore a c t i v e
T cells ameliorate the pathogenic potential of the autore a c t i v e
T-cell subset that re q u i res the N-terminal flanking region of
C L I P. Coadministration of both subsets of T cells resulted in a
consistent decrease in epithelial cell damage and a decrease in
the intensity of lymphocyte infiltration into the epiderm i s .
These results are in accord with observations from sev-
eral diff e rent animal model systems, clearly correlating a dif-
f e rential pattern of pathogenicity depending on the cytokine
p ro file of the reactive T cells [20-23]. Studies by Fowler et
al. [23] and Krenger et al. [22] clearly indicate that allore a c-
tive CD8+ T cells can be separated into cells secreting type 1
or type 2 cytokines. The cells secreting type 1 cytokines
mediated severe GVHD, whereas the cells secreting type 2
cytokines were ineffective in the same murine systems. In
addition, helper T cells secreting type 1 cytokines have also
been associated with severe GVHD, whereas helper T cells
s e c reting type 2 cytokines were largely ineffective [23-26].
Most important, however, were the findings that type 2
c y t o k i n e - s e c reting cells can ameliorate the severity of
GVHD and the associated lipopolysaccharide-induced
lethality mediated by Th1 cells [24-26]. Similar findings have
been re p o rted in other animal models of autoimmunity in
which pathogenic and protective autoreactive T cells can be
distinguished by their cytokine pro file [27-29].
A general finding applicable to many autoimmune
model systems suggest that Th1 cells mediate or accentuate
autoimmune disease, whereas Th2 (producing IL-4, IL-10)
Figure 8. Analysis of cytokines in acute and chronic syngenic graft-versus-
host disease (GVHD). Target tissue (tongue) harvested from animals during
the acute and chronic phases of syngeneic GVHD (confirmed histologically)
was analyzed by quantitative reverse transcription-polymerase chain reaction
for the cytokine profile of the infiltrating mononuclear cells. Included as a con-
trol was an animal who had complete resolution of acute syngeneic GVHD but
did not progress to the chronic phase. The mRNA from the tissues was
extracted and converted to cDNA. For the cytokine analysis, control templates
were added to each reaction. The bands were visualized with ethidium bro-
mide, the gels scanned densitometrically and the control template/sample signal
ratio calculated [17]. 
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or Th3 (producing IL-4, IL-10, TGF-β) either do not
cause pathology but may be protective from the pathogenic
e ffects of the effector T cells [28,29]. Strategies to tre a t
autoimmune disease in murine models rely primarily on
attempting to induce a switch in the cytokine pro d u c t i o n
p a t t e rn of the autoreactive T cells [30]. The mechanism by
which the C-term i n a l – restricted CLIP-autoreactive T- c e l l
clones exert their immunore g u l a t o ry effect remains unclear.
This subset of autoreactive T cells was unable to dire c t l y
kill the pathogenic T cells (N-term i n a l – restricted CLIP-
a u t o reactive T-cell clones).
The failure to kill the pathogenic effector T-cell mediat-
ing the acute GVHR response may be due to a failure to
express the relevant target or to a resistance to being killed.
P revious studies in our laboratory have suggested that 1 level
of regulation is the clonal deletion of the autore a c t i v e
T cells by a re g u l a t o ry T-cell subset [31]. The autore a c t i v e
T-cell clones are clonally deleted by primed CD4+ re g u l a t o ry
T cells via a Fas/FasL mechanism, leading to apoptotic cell
death [32]. Susceptibility to being killed by this mechanism
can depend on the cell cycle, with activated T cells being
m o re resistant to apoptotic death [33]. On the other hand, the
c u rrent studies reveal that the C-terminal CLIP-autore a c t i v e
T-cell clones induce a downregulation of message for type 1
cytokines. The downregulation of mRNA for these cytokines
can be mediated by both IL-10 and TGF-β p roduced by the
C - t e rminal CLIP-autoreactive T-cell clones [34,35]. These
results suggest that 1 level of immunoregulation may be the
d o w n regulation of type 1 cytokine production by the autore-
active effector T cells restricted by the N-terminal fla n k i n g
region of CLIP. As yet, other potential mechanisms such as
the induction of anergy cannot be excluded.
The failure to previously demonstrate any in vivo patho-
genic potential of the C-terminal CLIP-autoreactive T- c e l l
clone was surprising, given that this subset of T-cell clones
could effectively target and kill cells in vitro [2,14]. Even
i n c reasing the length of time of incubation from 48 to 96
hours did not reveal any remarkable pathology after injection
of this subset of T-cell clones. Retro s p e c t i v e l y, it appears that
a critical component was missing; the upregulation of the
MHC class II-CLIP target antigen. Administration of these
clones in the presence of IFN-γ revealed a remarkable pathol-
ogy located primarily in the dermis and deep dermis re g i o n s .
The histopathology included intense lymphocyte infiltrates in
the dermis, swelling, some glandular destruction, fibrin depo-
sition, infiltration of lymphocytes into the muscle layer, and
focal damage at the base of the epiderm a l - d e rmal junction.
Histopathology within the dermis was not observed when
type 1 (including IFN-γ) and type 2 cytokine–pro d u c i n g
clones were coadministered in the mixing studies even after
96 hours. Failure to detect histologic changes in this setting is
p robably due to the downregulation of IFN-γ p ro d u c t i o n .
The histopathologic changes observed after injection of
the C-terminal CLIP-reactive clones and IFN-γ a re consis-
tent with the initial onset or exacerbation of chro n i c - t y p e
GVHD [36]. It is unclear whether the disease process would
continue to advance to the classic histologic picture of a
c h ronic-type GVHD with the development of marked fib ro-
sis, sclero d e rma, or lichen planus [36]. The local GVHR
a ssay used in these studies may not be amenable to detection
of development of this classic chronic GVHD pathology.
P ro g ression of the disease and the development of severe
fibrosis after allogeneic BMT, however, are associated with
type 2 cytokines in the target tissue, particularly IL-4 and
T G F -β [37-39]. These cytokines are produced by the
C -t e rm i n a l – restricted CLIP-autoreactive T-cell clones. In
a c c o rdance with the studies of the T-cell clones in the local
GVHR assay are the results analyzing the cytokine pro fil e s
of lymphocytes infiltrating into the tissues during the acute
and chronic phases of syngeneic GVHD. The results indi-
cate that type 1 cytokines are pre f e rentially detected in the
tissue during the acute phase, whereas type 2 cytokines are
dominant in the chronic phase of syngeneic GVHD. Consis-
tent with these observations are the results from ongoing
studies using a competitive RT-PCR for Vα gene analysis of
the tissue-infiltrating lymphocytes. During the acute phase,
Vα 11 is detected principally with a shift to Vα 10 during the
c h ronic phase, clearly paralleling the activity of the N-term i-
nal (Vα 11) and C-terminal (Vα 10) CLIP-reactive clones.
P revious studies in the syngeneic GVHD model also
reveal that CD4+ T cells are critical for pro g ression fro m
acute syngeneic GVHD to the chronic phase of this
a u t o a g g ression syndrome [40]. Cert a i n l y,  the CD4+
T cells could provide cytokine amplification of the
e ffector T cells. Although we can isolate autore a c t i v e
C D 4+ T cells, evaluating these clones in the local GVHR
assay induced massive swelling that precluded an accurate
histopathologic assessment and is in accord with pre v i o u s
o b s e rvations [41,42].
Results from these studies suggest that there are 2 dis-
tinct populations of CD8+ a u t o reactive T cells associated
F i g u r e 9. Analysis of transforming growth factor (TGF)-β and tumor
necrosis factor (TNF)-α mRNA messages in acute and chronic syngenic graft-
versus-host disease (GVHD). Target tissues (tongue) from animals with
biopsy-confirmed acute and chronic syngeneic GVHD were analyzed by reverse
transcription-polymerase chain reaction for TGF-β and TNF-α m R N A .
Actin was also amplified in each reaction and served as a control semiquantita-
tive indicator for cDNA. MW Stds indicates molecular weight standards.
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with syngeneic GVHD, which differ with respect to their
antigen specific i t y, cytokine pro file, and pathogenic poten-
tial. The autoreactive T-cell clones that require the N-ter-
minal flanking region of CLIP for recognition of the MHC
class II-CLIP target antigen are associated primarily with
the acute phase of syngeneic GVHD. The production of
type 1 cytokines may underlie, in part, the pathogenicity of
these clones. A second subset of autoreactive T-cell clones
restricted by the C-terminal flanking region of CLIP has
unexpected immunoregulatory potential, because it modifies
the pathogenicity of the N-terminal–restricted clones ame-
liorating their potential to induce changes consistent with
an acute GVHR. This subset of clones that secrete type 2
cytokines does have the potential to mediate significant
p a t h o l o g y, but this action depends on externally supplied
IFN-γ leading to the upregulation of the target tissue anti-
gen. These results suggest that although these clones have
i m m u n o re g u l a t o ry potential, it is not without a pathologic
consequence. After the upregulation of MHC class II anti-
gens, these clones are able to mediate changes that are
remarkably similar to early-phase chronic GVHD and may
be a compensatory mechanism in response to the damage
mediated during the acute phase of syngeneic GVHD. The
systemic transition from acute to chronic syngeneic GVHD
and the ability to induce similar pathology with isolated T-cell
clones may be useful models for dissecting the role of
cytokines in this unique autoaggression syndrome. Current
studies with these models are evaluating whether systemic
administration of anti–IFN-γ or other cytokine antibodies
can dampen or prevent acute and chronic syngenic GVHD.
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